144 related articles for article (PubMed ID: 38240808)
1. Correction to: Split scar sign to predict complete response in rectal cancer after neoadjuvant chemoradiotherapy: systematic review and meta-analysis.
Torri GB; Wiethan CP; Langer FW; de Oliveira GS; Meirelles AVB; Horvat N; Tse JR; Dias AB; Altmayer S
Eur Radiol; 2024 Jan; ():. PubMed ID: 38240808
[No Abstract] [Full Text] [Related]
2. The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer.
Santiago I; Barata M; Figueiredo N; Parés O; Henriques V; Galzerano A; Carvalho C; Matos C; Heald RJ
Eur Radiol; 2020 Jan; 30(1):224-238. PubMed ID: 31350587
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of modified MRI-based split scar sign (mrSSS) score for pathological complete response after neoadjuvant chemoradiotherapy for patients with rectal cancer.
Yuan Y; Zheng K; Zhou L; Chen F; Zhang S; Lu H; Lu J; Shao C; Meng R; Zhang W; Gao X; Shen F
Int J Colorectal Dis; 2023 Feb; 38(1):40. PubMed ID: 36790595
[TBL] [Abstract][Full Text] [Related]
4. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
[TBL] [Abstract][Full Text] [Related]
5. Effect of adjuvant chemotherapy on the oncological outcome of rectal cancer patients with pathological complete response.
Yang J; Deng Q; Cheng Y; Fu Z; Wu X
World J Surg Oncol; 2024 Jan; 22(1):31. PubMed ID: 38273352
[TBL] [Abstract][Full Text] [Related]
6. Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Zhang Q; Liang J; Chen J; Mei S; Wang Z
Asian Pac J Cancer Prev; 2021 May; 22(5):1607-1611. PubMed ID: 34048192
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability and response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis.
O'Connell E; Reynolds IS; McNamara DA; Prehn JHM; Burke JP
Surg Oncol; 2020 Sep; 34():57-62. PubMed ID: 32891354
[TBL] [Abstract][Full Text] [Related]
8. Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
Ryan JE; Warrier SK; Lynch AC; Ramsay RG; Phillips WA; Heriot AG
Colorectal Dis; 2016 Mar; 18(3):234-46. PubMed ID: 26531759
[TBL] [Abstract][Full Text] [Related]
9. Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
Liu S; Jiang T; Xiao L; Yang S; Liu Q; Gao Y; Chen G; Xiao W
Oncologist; 2021 Sep; 26(9):e1555-e1566. PubMed ID: 33987952
[TBL] [Abstract][Full Text] [Related]
10. A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study.
Ke J; Jin C; Tang J; Cao H; He S; Ding P; Jiang X; Zhao H; Cao W; Meng X; Gao F; Lan P; Li R; Wu X
Dis Colon Rectum; 2023 Dec; 66(12):e1195-e1206. PubMed ID: 37682775
[TBL] [Abstract][Full Text] [Related]
11. Local Excision Techniques for Rectal Cancer After Neoadjuvant Chemoradiotherapy: What Are We Doing?
Smith FM; Ahad A; Perez RO; Marks J; Bujko K; Heald RJ
Dis Colon Rectum; 2017 Feb; 60(2):228-239. PubMed ID: 28059920
[TBL] [Abstract][Full Text] [Related]
12. The risk of nodal disease in patients with pathological complete responses after neoadjuvant chemoradiation for rectal cancer: a systematic review, meta-analysis, and meta-regression.
Wee IJY; Cao HM; Ngu JC
Int J Colorectal Dis; 2019 Aug; 34(8):1349-1357. PubMed ID: 31273449
[TBL] [Abstract][Full Text] [Related]
13. Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature.
Foster JD; Jones EL; Falk S; Cooper EJ; Francis NK
Dis Colon Rectum; 2013 Jul; 56(7):921-30. PubMed ID: 23739201
[TBL] [Abstract][Full Text] [Related]
14. Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis.
Ma B; Ren Y; Chen Y; Lian B; Jiang P; Li Y; Shang Y; Meng Q
Int J Colorectal Dis; 2019 Jan; 34(1):113-121. PubMed ID: 30368569
[TBL] [Abstract][Full Text] [Related]
15. [Clinical factors of pathological complete response after neoadjuvant chemoradiotherapy in rectal cancer].
Sha YJ; Wu HT; Wen XY; Wang CB
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):859-863. PubMed ID: 32234159
[No Abstract] [Full Text] [Related]
16. Effect of pathological complete response after neoadjuvant chemoradiotherapy on postoperative complications of rectal cancer: a systematic review and meta-analysis.
Yang J; Wang W; Luo Y; Huang S; Fu Z
Tech Coloproctol; 2022 Mar; 26(3):163-174. PubMed ID: 35048217
[TBL] [Abstract][Full Text] [Related]
17. Mucinous Rectal Adenocarcinoma Is Associated with a Poor Response to Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis.
McCawley N; Clancy C; O'Neill BD; Deasy J; McNamara DA; Burke JP
Dis Colon Rectum; 2016 Dec; 59(12):1200-1208. PubMed ID: 27824706
[TBL] [Abstract][Full Text] [Related]
18. Current evidence regarding the role of adjuvant chemotherapy in rectal cancer patients with pathologic complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
Baloyiannis I; Perivoliotis K; Vederaki S; Koukoulis G; Symeonidis D; Tzovaras G
Int J Colorectal Dis; 2021 Jul; 36(7):1395-1406. PubMed ID: 33772323
[TBL] [Abstract][Full Text] [Related]
19. [Predictive factors associated with pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer].
Sun Y; Chi P; Xu B; Lin H; Lu X; Huang Y; Xu Z; Huang S; Jiang C
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):556-60. PubMed ID: 24953361
[TBL] [Abstract][Full Text] [Related]
20. Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
Lai IL; You JF; Tsai WS; Hsu YJ; Chern YJ; Wu MY
World J Surg Oncol; 2023 Jul; 21(1):224. PubMed ID: 37491250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
